Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global ...
The elastomeric infusion pumps market is poised to grow from USD 1.15 billion in 2025 to USD 1.49 billion by 2030, at a CAGR of 5.3%. Increasing demand in oncology, pain management, anesthesia, and ...
Much of Medtronic’s work in diabetes this year has focused specifically on bringing new technologies to European patients—and its latest purchase continues this trend. The medtech giant snapped up the ...
DUBLIN--(BUSINESS WIRE)--The "Infusion Pumps and Devices: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. Infusion pumps are widely used in hospitals, ...
Of the roughly 1.5 million adverse drug events are reported annually to the FDA, more than half are attributed to infusion-related errors. The automated pumps that ...
LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global programmable infusion pumps market and the market is poised to grow by USD 487.81 million during 2020-2024 at a CAGR of almost 8% ...
The Freedom60 Infusion Pump is designed to support dosing with 50 ml prefilled syringes, while the FreedomEDGE® Infusion System provides a compatible option for 20 mL prefilled syringe formats.
The FDA has expanded the indication for Fiasp (insulin aspart injection; Novo Nordisk) 100 Units/mL to include use in insulin infusion pumps to improve glycemic control in adults with type 1 or type 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results